Close
Nordic 9Nordic 9

Novartis Venture Fund (investor - Corporate Investor)

Switzerland nvfund.com
See something wrong or missing? Let us know
Offices:Basel

Novartis Venture Funds is a private equity and venture capital arm of Novartis AG specializing in stage agnostic investments (seed to commercial companies)  in Biotechnology/Biopharma life sciences companies from multiple therapeutic areas where there is clear unmet medical need.

Average round investment:56.18M USD
Average number per year:3.0
Distribution: 2025 (4)2024 (5)2023 (3)2022 (4)2021 (4) See the entire list
Portfolio companies: United Kingdom Artios PharmaUnited Kingdom NRG TherapeuticsSpain Splice Bio See the entire list
Mostly invests in: United Kingdom United Kingdom (8) Health services (23)
See the entire list

Showing 3 of 24 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Novartis Venture Fund mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Novartis Venture Fund

Name Criteria
United Kingdom One Peak Partners
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Ireland
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
South Korea Samsung Ventures
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Spain, Netherlands, Finland
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United States Meritech Capital Partners
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Netherlands
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United Kingdom IAG Silverstripe
92%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Ireland
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United States Felicis Ventures
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Spain, Netherlands, Finland, Ireland
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
Switzerland Pictet Group
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Netherlands
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United States F-Prime Capital
91%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Netherlands
  • Average number of deals per year: 4.1
  • Active last 12 months: Yes
Netherlands Snowflake Software
90%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Spain
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Germany Burda Principal Investments
90%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany, Spain
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Hong Kong Horizons Ventures
90%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Switzerland, Germany, Netherlands
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Top